Bifogade filer
PDF
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Denmark |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S (Stenocare) is currently offering new shares at a discounted rate of DKK 2.11 for TO1 Warrant owners and, through the acquisition of Warrants, new investors. The deadline for trading TO1 Warrants is end of business day December 15
Deadline for trading TO1 Warrants: The important deadline for trading is December 15 at 16:59 (CET). Warrant owners who are not planning to exercise their TO1 Warrants have the opportunity to sell the warrants before the deadline. Investors that are interested in subscribing for the discounted new Stenocare shares at DKK 2.11 each, need to acquire TO1 Warrants before the deadline Dec 15 and exercise those warrants.
The offer: Stenocare completed a Share Issue in June 2023 that was subscribed with 127%. The participants also received additional rights to purchase more Stenocare shares at a discounted price during December 2023 and June 2024. These rights are called "TO1 Warrants" and "TO2 Warrants", and between December 6-19 one TO1 Warrant gives the holder a right to buy one new Stenocare shares at an discounted price of DKK 2.11 per share.
Opportunity for all to purchase additional Stenocare shares: It is possible for both current owners of TO1 Warrants and new investors to subscribe (ie purchase) additional new Stenocare shares at DKK 2.11 through the acquisition of TO1 Warrants. Holders of existing TO1 warrants use these to buy the new shares at DKK 2.11/each and/or buy additional TO1 warrants which can then be used (exercised) to buy new shares DKK 2.11/each. Anyone can buy TO1 Warrants under the ticker "STENO TO 1", and then exercise these for the purchase of new Stenocare shares. Please notice that last day for purchasing TO1 Warrants is December 15, and last day for exercising the TO1 Warrants is December 19.
CEO of Stenocare, Thomas Skovlund Schnegelsberg, comments: "We are near the first important deadline for making a decision to either use/exercise or sell the TO1 Warrants. Either way, warrant owners and investors need to act before December 15 at 16:59 (CET)."
For more information about the TO1 Warrant transaction and the Stenocare business case: https://stenocare.com/share-issue-to1-2023/
Sign-up for Stenocare news here: https://stenocare.com/subscribe-for-newsletter/ to automatically receive the latest news and information about the company.